Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
44,747,389
-
Shares change
-
+5,828,938
-
Total reported value, excl. options
-
$3,843,255,917
-
Value change
-
+$502,114,798
-
Put/Call ratio
-
62%
-
Number of buys
-
144
-
Number of sells
-
-100
-
Price
-
$85.95
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2019
300 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2019.
REPLIGEN CORP - COMMON STOCK (RGEN) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,747,389 shares
of 56,222,082 outstanding shares and own 80% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,350,552 shares), VANGUARD GROUP INC (4,420,485 shares), Invesco Ltd. (3,088,594 shares), WELLINGTON MANAGEMENT GROUP LLP (2,321,167 shares), FRED ALGER MANAGEMENT INC (1,849,438 shares), STATE STREET CORP (1,835,799 shares), Conestoga Capital Advisors, LLC (1,698,329 shares), FEDERATED INVESTORS INC /PA/ (993,969 shares), MACQUARIE GROUP LTD (985,047 shares), and DIMENSIONAL FUND ADVISORS LP (794,132 shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.